Biotech Business Advises on Clinical Collaboration Agreement with Roche/Genentech.

Biotech Business Advises on Clinical Collaboration Agreement with Roche/Genentech

November - 2017

Biotech Business’s client, Biothera Pharmaceuticals Inc., Eagan MN (www.biothera.com) announced today a clinical collaboration with Genentech, Inc., a member of the Roche Group. The collaboration will evaluate the combination of Biothera’s innate immune modulator, Imprime PGG, in combination with Genentech’s checkpoint inhibitor, atezolizumab, and anti-VEGF therapy, bevacizumab in late stage metastatic colorectal cancer. 

For more information see: 
https://www.biothera.com/biothera-pharmaceuticals-enters-cancer-immunotherapy-clinical-trial-collaboration-agreement/

Comments are closed.